longbridge

Obsidian Therapeutics

OBX
----

All Shareholders

Shareholder Type

  • Public and others65.43%
  • Institutions13.65%
  • VC/PE firms11.89%
  • Hedge funds6.64%
  • Individuals & Insiders2.39%

Major Shareholders

Major Shareholders Latest
Shareholder
RA Capital Management, L.P.
6.77%4.18M--+4.18M
Paradigm Biocapital Advisors LP
6.64%4.10M--+4.10M
Atlas Venture Advisors, Inc.
5.12%3.16M--+3.16M
Vanguard Capital Management, LLC
4.42%2.73M--+2.73M
Deep Track Capital, LP
3.77%2.33M--+2.33M
Novo Holdings A/S
3.55%2.19M--+2.19M
Madan JagasiaPresident, CEO & Director
1.46%903.50K--+903.50K
Franklin Templeton Inc.
1.35%833.30K--+833.30K
Charles Schwab Investment Management, Inc.
0.44%269.13K--+269.13K
Parameswaran HariChief Medical Officer
0.37%230.25K--+230.25K
Dana AlexanderChief Technical Officer
0.24%146.06K--+146.06K
Maria FardisExecutive Chairman of the Board
0.16%97.54K--+97.54K
BlackRock, Inc.
0.10%61.73K--+61.73K
Robert RossIndependent Director
0.07%43.34K--+43.34K
Heidi HagenIndependent Director
0.06%35.90K--+35.90K
Matthew NorkunasIndependent Director
0.03%19.79K--+19.79K
Geode Capital Management, LLC
0.03%16.47K--+16.47K
T. Rowe Price Group, Inc.
<0.01%635.00--+635.00
SBI Holdings, Inc.
0.00%1.00--+1.00
© 2026 Longbridge｜Terms of ServicePrivacy Policy